H. pylori eradication regimens — the combination antibiotic therapy programs incorporating PPIs for acid suppression that enhance antibiotic efficacy against the gastric pathogen — represent a major PPI clinical application with evolving regimens driven by antibiotic resistance, with the Proton Pump Inhibitors Market reflecting H. pylori eradication as an important PPI market...